ANVISA registration

Teste Rápido de Antígeno para SARS-CoV-2 GlobalX AT

Registration 82568320016. CORONAVÍRUS

Registration details

Registration number82568320016
Application number25351215186202515
Technical nameCORONAVÍRUS
Risk classIII
Published on02/03/2026
ValidityValid until 02/03/2036

Registration holder

Legal nameGLOBALX PHARMA LTDA.
CNPJ41.775.241/0001-90

Manufacturer

  • HANGZHOU ALLTEST BIOTECH CO. LTD CHINA, REPÚBLICA POPULAR

Other registrations held by GLOBALX PHARMA LTDA.view all

Teste rápido em cassete de HIV 1.2

82568320001

Teste rápido em cassete de Sífilis

82568320002

Teste Rápido em Cassete de HBsAg

82568320003

Teste Rapido em Cassete de HCV

82568320004

Teste Rapido em Cassete de HIV 1.2 e Sífilis GlobalX

82568320005

Teste Rápido em Cassete de HBsAg GlobalX OG

82568320006

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist